- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rituximab - Bendamustine
Total 3305 results
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; CephalonTerminatedBrain MetastasesUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Hoffmann-La RocheActive, not recruitingChronic Lymphocytic Leukemia (CLL)United States, Italy, Australia, Spain, France
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Spain, Belgium, Austria, Czechia, Australia, Italy, Japan, Hungary, United Kingdom, Taiwan, Turkey, Germany, Canada, France, Israel, Poland, Croatia, Korea, Republic of, Ireland, Russian Federation, Singapore, Sw...
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
Novartis PharmaceuticalsTerminatedLymphoma, FollicularUnited States, Belgium, Italy, Hong Kong, Austria, Germany, Japan, Russian Federation, United Kingdom, Canada, Slovakia, Poland, Ukraine, Puerto Rico, Greece, France, Argentina
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
CephalonCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Non-Hodgkin's LymphomaItaly
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's LymphomaJapan
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNon-Hodgkin Lymphoma by Clinical CourseChina
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
German Breast GroupCompleted
-
German CLL Study GroupGilead Sciences; Novartis PharmaceuticalsCompletedChronic Lymphocytic LeukemiaGermany
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Canada, Puerto Rico
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.CompletedT-cell LymphomaFrance
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States, Canada
-
SymBio PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedLymphoma, Non-HodgkinUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedBendamustine | Conditioning Therapy | Autologous Stem Cell Transplant | Aggressive Non Hodgkin's LymphomaSpain
-
Jiangsu Simcere Pharmaceutical Co., Ltd.CompletedChronic Lymphocytic LeukemiaChina
-
Washington University School of MedicineCompletedMantle Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Novartis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCGlaxoSmithKline; Novartis; CephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedNon-Hodgkin's Lymphoma | Indolent Non-follicularItaly
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Zhengzhou UniversityRecruitingNewly Diagnosed Mantle Cell LymphomaChina
-
CelgeneActive, not recruitingNeoplasmsUnited States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
Fate TherapeuticsRecruitingAdvanced Solid TumorUnited States
-
M.D. Anderson Cancer CenterNational Comprehensive Cancer Network; CephalonCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
St. Petersburg State Pavlov Medical UniversityN.N. Petrov National Medical Research Center of OncologyRecruitingHodgkin LymphomaRussian Federation
-
Sidney Kimmel Cancer Center at Thomas Jefferson...WithdrawnMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
Peter MoosmannKantonsspital AarauCompletedLymphoma, Non-Hodgkin
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLymphoma | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Lymphocytic NeoplasmUnited States
-
CelgeneCompletedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, United Kingdom, Germany, France, Italy, Netherlands, Japan
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Arbeitsgemeinschaft medikamentoese TumortherapieMundipharma Pte Ltd.CompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
University of LiverpoolGlaxoSmithKline; Chugai Pharma USA; Napp Pharmaceuticals LimitedUnknownChronic Lymphocytic LeukaemiaUnited Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States